US 8,895,698 B2Granted

Binding partners of antibodies specific for dendritic cell antigens

AssigneeThe Corporation of the Trustees of the Order of the Sisters of Mercy in Queensland

InventorsDerek Nigel Hart, David Munster, Peter Vukovic

Life of this patent

Estimating the term…

Abstract

The present invention relates to the field of diagnostics, therapeutics and immunological reagents. More particularly, the present invention provides binding partners of antibodies specific for dendritic cell (DC) antigens. The present invention further provides diagnostic and/or therapeutic agent based on the binding partners or antibodies specific for the binding partners.

Claims6

Dependent claims

An isolated peptide comprising the amino acid sequence set forth in SEQ NO:

10 (AQKYQGIHIWPR), wherein said peptide binds to CMRF44Ab.

Dependencies are inferred from the claim text.

Facts

Application: 13/606,665Filed 7 Sep 2012 · division
Priority: AU 200490706910 Dec 2004
Published: US 2013/0085261 A14 Apr 2013
Granted: 25 Nov 2014
Term ends: Not estimatedThe source records don’t support an estimate.

Classification12 codes

C07K 7/08
Linear peptides containing only normal peptide links: having 12 to 20 amino acids
A61P 37/00
Drugs for immunological or allergic disorders
A61P 37/04
Immunomodulators: immunostimulants
C07K 7/06
Linear peptides containing only normal peptide links: having 5 to 11 amino acids

Family

PCT/AU2005/001864Parent of this division · filed 9 Dec 2005
US 2013/0085261 A1Pre-grant publication · published 4 Apr 2013
Application11/721,425Parent of this division
US 2010/0111980 A1Published application
US 8,895,698 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results